CSIMarket
 
Idexx Laboratories Inc  (NASDAQ: IDXX)
 

Idexx Laboratories Inc's Suppliers Performance

IDXX's Supply Chain




 
IDXX Costs vs Sales of Suppliers Growth Idexx Laboratories Inc recorded an increase in cost of sales by 5.68 % year on year, sequentially cost of sales grew by 4.66 % in Q2.

• More on IDXX Suppliers



Idexx Laboratories Inc recorded increase in cost of sales by 5.68 % year on year, sequentially cost of sales grew by 4.66 % in Q2.

• More on IDXX Suppliers




Idexx Laboratories Inc's Comment on Supply Chain


The company sources raw materials and consumables from third-party suppliers, including sole and single-source providers. To manage supply risks, the company identifies alternative suppliers, develops in-house manufacturing capabilities, utilizes escrow arrangements, and maintains safety stock. Key products supplied by sole or single-source providers include Catalyst Dx and Catalyst One consumables, ProCyte Dx Analyzers and consumables, IDEXX inVue Dx cytology consumables, SediVue Dx urinalysis instruments and consumables, and components for internally manufactured analyzers. Certain Catalyst chemistry slides are supplied by Ortho-Clinical Diagnostics, Inc. under agreements expiring in 2044, which require the company to purchase all requirements from Ortho if supply is available. Other analyzers and consumables are acquired under agreements extending through 2034. Additional sole and single-source supplied products include diagnostic imaging systems, SNAP rapid assay and dairy devices, livestock and poultry testing kits, and water testing products. The company maintains product quality and safety through an Integrated Management System and Quality Assurance program.

Idexx Laboratories Inc's Comment on Supply Chain


The company sources raw materials and consumables from third-party suppliers, including sole and single-source providers. To manage supply risks, the company identifies alternative suppliers, develops in-house manufacturing capabilities, utilizes escrow arrangements, and maintains safety stock. Key products supplied by sole or single-source providers include Catalyst Dx and Catalyst One consumables, ProCyte Dx Analyzers and consumables, IDEXX inVue Dx cytology consumables, SediVue Dx urinalysis instruments and consumables, and components for internally manufactured analyzers. Certain Catalyst chemistry slides are supplied by Ortho-Clinical Diagnostics, Inc. under agreements expiring in 2044, which require the company to purchase all requirements from Ortho if supply is available. Other analyzers and consumables are acquired under agreements extending through 2034. Additional sole and single-source supplied products include diagnostic imaging systems, SNAP rapid assay and dairy devices, livestock and poultry testing kits, and water testing products. The company maintains product quality and safety through an Integrated Management System and Quality Assurance program.







IDXX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Idexx Laboratories Inc 41,183.55 4,553.79 1,139.66 11,000
SUBTOTAL 0.00 0.00 0.00 -


Sources: Idexx Laboratories Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Idexx Laboratories Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.